Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News BioRestorative Therapies Inc BRTX

Healthcare Biotechnology
BioRestorative Therapies, Inc. is engaged in developing therapeutic products and medical therapies using cell and tissue protocols, primarily involving adult stem cells. The Company has two core programs that relate to the treatment of disc/spine disease and metabolic disorders. Its lead cell therapy candidate, BRTX-100, is a product formulated from autologous (or a person's own) cultured... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:BRTX)

BioRestorative Announces FDA Clearance of IND for Phase 2 Trial of BRTX-100 in Chronic Cervical Discogenic Pain

GlobeNewswire February 27, 2025

BioRestorative Announces Updated Time for February 27th Webcasted Conference Call to Discuss Clinical Pipeline Update

GlobeNewswire February 26, 2025

BioRestorative to Provide a Positive FDA Update on Clinical Pipeline

GlobeNewswire February 25, 2025

BioRestorative Receives FDA Fast Track Designation for BRTX-100 Chronic Lumbar Disc Disease Program

GlobeNewswire February 20, 2025

BRTX-100 Front and Center at ORS 2025

GlobeNewswire February 10, 2025

BioRestorative Therapies Announces Notice of Allowance of Key New Patent Protecting ThermoStem® Metabolic Disease Program

GlobeNewswire December 5, 2024

BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data

GlobeNewswire November 13, 2024

BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire November 12, 2024

BioRestorative Therapies to Present New Clinical Data at the ORS PSRS 7th International Spine Research Symposium

GlobeNewswire November 6, 2024
View More News ››

Opinion & Analysis (NDAQ:BRTX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:BRTX)

Buy buddy buy because it's taking off this morning.

This stock is signalling a big upswing for it today
coolfooldumbguy - February 20, 2025

BioRestorative Therapies (BRTX): Pioneering Cell-Based Thera

Looks like BRTX is making some serious moves in the cell therapy space. Those Phase 2 trial results are looking spicy - 70% of patients...
MikeTester - January 24, 2025

Watching and waiting to see

If this stock is good for a day trade or not but we will see in the morning.
coolfooldumbguy - December 5, 2024

BioRestorative Therapies Announces Notice of Allowance of Ke

NEWS: $BRTX BioRestorative Therapies Announces Notice of Allowance of Key New Patent Protecting ThermoStem&#xAE; Metabolic Disease...
whytestocks - December 5, 2024

BioRestorative Therapies, Inc. (NASDAQ:BRTX): Pioneering Cel

http://beyondspx.com/2024/08/01/biorestorative-therapies-inc-nasdaqbrtx-pioneering-cell-based-therapies-for-chronic-conditions/
MikeTester - August 2, 2024

BRTX.....another early a.m runner on NR

Lots of Volume & Price action.....warrants are being exercise at reduced price of $2.33 Could rally from here....again....Stops...
Iseneschal - June 13, 2024
View more Bullboard ››

Lode Gold Resources Inc.

Lode Gold Resources Inc.

Lode Gold Resources Inc. is a Canadian exploration and development company with grassroots and advanced exploration ...
View More »